Search

A comprehensive analysis of over 25 million pregnancies indicates that the use of antidepressants during pregnancy does not increase the risk of developmental disorders such as autism or ADHD in children, challenging claims made by U.S. Health Secretary Robert F. Kennedy Jr., and highlighting the need for careful consideration of maternal mental health during pregnancy. #MentalHealth #Pregnancy #AutismResearch #US #HK #UK

A comprehensive analysis of data from over 25 million pregnancies indicates that the use of antidepressants during pregnancy does not increase the risk of developmental disorders like autism or ADHD in children, challenging claims made by U.S. Health Secretary Robert F. Kennedy Jr. about potential risks associated with these medications. #MentalHealth #Pregnancy #AutismResearch #US #HK #UK

A recent analysis of data from over 25 million pregnancies found that the use of antidepressants during pregnancy does not increase the risk of developmental disorders like autism or ADHD in children, contradicting claims made by U.S. Health Secretary Robert F. Kennedy Jr. regarding potential risks associated with these medications. #MentalHealth #Pregnancy #ChildDevelopment #US #HK #UK

A recent analysis of over 25 million pregnancies indicates that the use of antidepressants during pregnancy does not significantly increase the risk of developmental disorders such as autism or ADHD in children, contradicting claims made by U.S. Health Secretary Robert F. Kennedy Jr. #MentalHealth #Pregnancy #AutismResearch #US #HK #UK

A recent analysis of over 25 million pregnancies indicates that the use of antidepressants during pregnancy does not increase the risk of developmental disorders like autism, contradicting unfounded assertions made by U.S. Health Secretary Robert F. Kennedy Jr., while also highlighting the significance of maternal mental health in assessing potential risks to children. #MentalHealth #Pregnancy #AutismResearch #US #HK #UK

Health Secretary Robert F. Kennedy Jr. recently announced initiatives to encourage people to reconsider their use of antidepressants, particularly S.S.R.I.s, emphasizing the importance of individualized decisions in collaboration with healthcare providers and providing expert guidance on when and how to safely discontinue these medications. #MentalHealth #Antidepressants #DepressionSupport #US #GB

Health Secretary Robert F. Kennedy Jr. announced initiatives to encourage individuals to reconsider the use of antidepressants, particularly S.S.R.I.s, while experts emphasize that the decision to stop should be made collaboratively with a healthcare provider, taking into account individual recovery, potential withdrawal symptoms, and the risks of relapse, with a general recommendation to taper off the medication gradually and safely. #MentalHealth #Antidepressants #Deprescribing #US #GB

U.S. Health Secretary Robert F. Kennedy Jr. is proposing initiatives to reduce the use of widely prescribed selective serotonin reuptake inhibitors (SSRIs) despite the department denying discussions about banning them, amidst ongoing debates about their overprescription and links to withdrawal challenges and violence, while emphasizing the need for better research and support for patients. #MentalHealth #Pharmaceuticals #Antidepressants #US

Health Secretary Robert F. Kennedy Jr. has introduced new initiatives aimed at reducing the prescription of selective serotonin reuptake inhibitors (SSRIs) in the U.S., promoting alternative treatments and involving clinicians more in guiding patients through discontinuation, amidst concerns of overprescription and withdrawal symptoms associated with these widely used antidepressants. #MentalHealth #Psychiatry #Overmedication #US #GB #DE